Skip to content
★ Sign in to follow
Synergy CHC Corp. logo

Synergy CHC Corp. Stock: price and insider trades · United States

US·Mcap US$1.3MHealth Care

No insider purchase over the last 90 days. The latest, by Ross Jack, was filed 31 Jul 2025.

Synergy CHC Corp.: what insiders have been doing

This page follows insider dealings at Synergy CHC Corp. as filed with SEC (Form 4), a company from the Health Care sector. Between 24 October 2025 and 24 October 2026, 2 insiders published 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Insider buying of Synergy CHC Corp. has been absent for the past year.

With 2 filings in twelve months, the company is quieter than the median of 24 filings across the 3,167 companies we follow on the same exchange. Over the whole record (from 2015), the tally stands at 127 purchases and no sales. The 10-K for the year ended 31 December 2025 shows 30.4 m USD of revenue and -12.3 m USD of net income.

Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
131
Thresholds
n/a
Buy Volume
€6M
127 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Jack Ross117 buys

Since the insiders bought

  • Filed 31 Jul 2025 · 465 days ago · €1,713
    -94.8%
    Entry US$3.36 · Close at T+365 US$0.17

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Synergy CHC Corp. Strong Buy (bullish), based on 1 analysts. Average price target: US$3.75.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.09
Analyst consensus
1 analysts
Strong buy
US$3.75Target US$3.75(+4044%)US$3.75
Income statement
RevenueUS$30.4M
Gross profitUS$20.3M67% margin
EBITDA-US$6.2M-20% margin
Net income-US$12.3M-57.0% margin
Valuation
PER (forward)0.6x
Beta0.64
Balance sheet & cash
Market capUS$1.3M
Total debtUS$26.8M
Free Cash Flow-US$2.6M
Profitability & ownership
ROA-62.0%
% insiders48.0%
% institutions4.5%
Last declaration on 24 April 2026
Declarations131 total
  • ◆
    DirectorExecutives
    0SEC
    306,433 shares0Common Stock, par value $0.00001 per shareSEC:0001782072-26-000001:0
  • ◆
    DirectorExecutives
    0SEC
    25,824 shares0Common Stock, par value $0.00001 per shareSEC:0002089979-26-000001:0
  • ▲
    CEO and ChairmanExecutives
    215 USD28SEC
    100 shares@ US$2.150.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001474506-25-000145:1
    Canonical exit: 11 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    248 USD28SEC
    100 shares@ US$2.480.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001474506-25-000145:3
    Canonical exit: 15 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    260 USD28SEC
    100 shares@ US$2.600.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001474506-25-000145:9
    Canonical exit: 25 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    369 USD28SEC
    100 shares@ US$3.690.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001474506-25-000145:23
    Canonical exit: 28 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,026 USD0SEC
    450 shares@ US$2.28Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:2
    Canonical exit: 14 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,338 USD0SEC
    600 shares@ US$2.23Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:4
    Canonical exit: 16 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    26,780 USD0SEC
    10,300 shares@ US$2.60Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:5
    Canonical exit: 18 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,044 USD0SEC
    400 shares@ US$2.61Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:6
    Canonical exit: 21 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,578 USD0SEC
    600 shares@ US$2.63Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:7
    Canonical exit: 22 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,658 USD0SEC
    650 shares@ US$2.55Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:8
    Canonical exit: 24 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    6,994 USD0SEC
    2,600 shares@ US$2.69Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:10
    Canonical exit: 28 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    763 USD0SEC
    250 shares@ US$3.05Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:11
    Canonical exit: 29 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    12,113 USD0SEC
    3,750 shares@ US$3.23Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:12
    Canonical exit: 30 Sept 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    5,635 USD0SEC
    1,750 shares@ US$3.22Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:13
    Canonical exit: 1 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    2,282 USD0SEC
    700 shares@ US$3.26Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:14
    Canonical exit: 5 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    2,688 USD0SEC
    800 shares@ US$3.36Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:15
    Canonical exit: 6 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,260 USD0SEC
    400 shares@ US$3.15Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:16
    Canonical exit: 7 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    4,466 USD0SEC
    1,400 shares@ US$3.19Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:17
    Canonical exit: 8 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    2,400 USD0SEC
    750 shares@ US$3.20Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:18
    Canonical exit: 9 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,062 USD0SEC
    300 shares@ US$3.54Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:19
    Canonical exit: 20 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,149 USD0SEC
    300 shares@ US$3.83Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:20
    Canonical exit: 22 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    1,365 USD0SEC
    350 shares@ US$3.90Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:21
    Canonical exit: 23 Oct 2025 (T+90)
  • ▲
    CEO and ChairmanExecutives
    915 USD0SEC
    250 shares@ US$3.66Common Stock, par value $0.00001 per shareSEC:0001474506-25-000145:22
    Canonical exit: 27 Oct 2025 (T+90)

25 of 131 declarations

About Synergy CHC Corp.

Synergy CHC Corp. is a NASDAQ-listed company focused on the development and marketing of health and wellness products. It aims to provide innovative solutions to enhance consumers' quality of life.